- Retraction Note
- Open Access
- Published:
Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research volume 41, Article number: 272 (2022)
Retraction Note: J Exp Clin Cancer Res 37, 49 (2018)
https://doi.org/10.1186/s13046-018-0717-3
The Editor-in-Chief has retracted this article at the corresponding author's request. After publication, the authors became aware that data from other projects were included in the figures, resulting in image overlap between this article and previous publications from other authors. Specifically:
Additionally, parts of images in Figs. 2d, 3a, 7g and 8f have subsequently been used in [3,4,5,6,7].
The authors have therefore lost confidence in the data presented in this article.
Author Kangsheng Tu has stated on behalf of all co-authors that they agree to this retraction.
References
Yang N, Chen J, Zhang H, et al. LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma. Cell Death Dis. 2017;8:e2975. https://doi.org/10.1038/cddis.2017.358.
Xu Q, Liu X, Liu Z, et al. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Mol Cancer. 2017;16:103. https://doi.org/10.1186/s12943-017-0675-y.
Yao B, Li Y, Wang L, et al. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9. Artif Cells Nanomed Biotechnol. 2019;47(1):3885–95. https://doi.org/10.1080/21691401.2019.1670190.
Zhou M, Chen J, Zhang H, et al. KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p. Int J Biol Sci. 2020;16(12):2063. https://doi.org/10.7150/ijbs.45999.
Yang N, Wang L, Chen T, et al. ZNF521 which is downregulated by miR-802 suppresses malignant progression of hepatocellular carcinoma through regulating Runx2 expression. J Cancer. 2020;11(19):5831. https://doi.org/10.7150/jca.45190.
Yang N, Chen T, Wang L, et al. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway. Theranostics. 2020;10(13):5790. https://doi.org/10.7150/thno.44789.
Liu Z, Mo H, Sun L, et al. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway. Cancer Sci. 2020;111:4118–28. https://doi.org/10.1111/cas.14631.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liu, Z., Wang, Y., Dou, C. et al. Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. J Exp Clin Cancer Res 41, 272 (2022). https://doi.org/10.1186/s13046-022-02487-y
Published:
DOI: https://doi.org/10.1186/s13046-022-02487-y